Preview

Kuban Scientific Medical Bulletin

Advanced search

CONTRAST-ENCHANCED ULTRASOUND IN THE DIFFERENTIAL DIAGNOSIS OF FOCAL NODULAR HYPERPLASIA AND HEPATIC ADENOMA

https://doi.org/10.25207/1608-6228-2019-26-2-50-63

Abstract

Aim. To increase the effectiveness of the differential diagnosis of benign focal lesions of the liver using contrast-enhanced ultrasound (CEUS).

Materials and methods. A retrospective analysis of the examination results of 37 patients with morphologically confi rmed liver benign tumors was carried out. According to the morphological data, the patients were divided into two groups: 22 patients with focal nodular hyperplasia (FNH) and 15 patients with hepatocellular adenoma (HCA). All the patients underwent multiparametric ultrasound examination using CEUS.

Results. According to the obtained data, despite the nearly equal intensity of fi lling FNH and HCA with a contrast agent (96% and 80%, accordingly), FNH is characterized by an earlier contrasting (WASH IN) pattern in the arterial phase (AF), with the ‘onset of contrasting in the focus’ parameter being signifi cantly different from HCA (p<0.05). Specifi c signs of FNH included the following: the spoke-wheel pattern and an increased intensity of ultrasound contrast agent (USCA) accumulation — 96% of cases; ‘center-to-edge’ fi lling — 86% of cases. WASH-OUT is not a typical sign of FNA. A complete (100% of cases) and intensive (80% of cases) centripetal (80% of cases) fi lling is characteristic of HCA. No specifi c types of vascular pattern were observed. In 6 (40%) patients, WASH-OUT and ‘relative hyperechoic’ were detected in the portal phase.

Conclusion. CEUS is established to be an effective method of the differential diagnosis of FNH and HCA. 

About the Authors

Alexey N. Katrich
Research Institute — Regional Clinical Hospital 1 n.a. Prof. S.V. Ochapovsky, Ministry of Healthcare of Krasnodar Krai; Kuban State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation

Cand. Sci. (Med.), Head of the Ultrasound Diagnostics Department, 1 Maya str., 67, Krasnodar, 350086;

Research Assistant, Department of Surgery No. 1, Faculty of Advanced Education, Mitrofanа Sedinа str., 4, Krasnodar, 350063



Nikolai S. Ryabinin
Research Institute — Regional Clinical Hospital 1 n.a. Prof. S.V. Ochapovsky, Ministry of Healthcare of Krasnodar Krai
Russian Federation

Cand. Sci. (Med.), Endoscopist, Endoscopy Department No. 2,

1 Maya str., 67, Krasnodar, 350086



Sergey V. Polshikov
Research Institute — Regional Clinical Hospital 1 n.a. Prof. S.V. Ochapovsky, Ministry of Healthcare of Krasnodar Krai
Russian Federation

Doctor Radiologist, Department of Ultrasound diagnostics, 

1 Maya str., 67, Krasnodar, 350086



Nikita A. Katrich
Kuban State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation

Student,

Mitrofanа Sedinа str., 4, Krasnodar, 350063



References

1. Garin A. M., Bazin I. S. Ten most common malignant tumors: monograph. 2nd ed. M.: MAKSPress; 2010. 380 p.

2. Claudon M., Dietrich C. F., Choi B. I., Cosgrove D. O., Kudo M., Nolsoe C. P., Piscaglia F., Wilson S. R., Barr R. G., Chammas M. C., Chaubal N. G., Chen M. H., Clevert D. A., Correas J. M., Ding H., Forsberg F., Fowlkes J. B., Gibson R. N., Goldberg B., Lassau N., Leen E. L. S., Mattrey R. F., Moriyasu F., Solbiati L., Weskott H. P., Xu H. X. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver — update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med. Biol. 2013; 39(2): 187–210. DOI: 10.1016/j.ultrasmedbio.2012.09.002

3. Marrero J. A., Ahn J., Rajender Reddy K., American College of G. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am. J. Gastroenter.2014; 109(9): 1328–1347. DOI: 10.1038/ajg.2014.213

4. Buscarini E., Danesino C., Plauchu H., de Fazio C., Olivieri C., Brambilla G., Menozzi F., Reduzzi L., Blotta P., Gazzaniga P., Pagella F., Grosso M., Pongiglione G., Cappiello J., Zambelli A. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med. Biol. 2004; 30(9): 1089–1097. DOI: 1016/j.ultrasmedbio.2004.08.004

5. Mindikoglu A. L., Regev A., Levi J. U., Casillas J., Schiff E. R. Focal nodular hyperplasia in identical twins. Am. J. Gastroenter. 2005; 100(7): 1616–1619. DOI: 10.1111/j.1572-0241.2005.41898

6. Colombo M. EASL Clinical Practice Guidelines on the management of benign liver tumours. J. Hepatol. 2016; 65(2): 386–398. DOI: 10.1016/j.jhep.2016.04.001

7. Paradis V., Benzekri A., Dargere D., Bieche I., Laurendeau I., Vilgrain V., Belghiti J., Vidaud M., Degott C., Bedossa P. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology. 2004; 126(5): 1323–1329. DOI: 10.1053/j.gastro.2004.02.005

8. Skipenko O. G., Chardarov N. K., Shatveryan G. A., Bagmet N. N., Bedzhanyan A. L., Fedorov D. N., Khovrin V. V., Fisenko E. P. Fokal’naya nodulyarnaya giperplaziya pecheni. Khirurgiya. 2012; 6: 73–82 (In Russ.).

9. Bonder A., Afdhal N. Evaluation of liver lesions. J. Clin. Liver Dis. 2012; 16(2): 271–283. DOI: 10.1016/j. cld.2012.03.001

10. Luk’yanchenko A. B., Medvedeva B. M. The current approaches to the diagnosis of hepatocellular adenomas (literature review аnd clinical cases). Meditsinskaya Vizualizatsiya. 2013; 1: 33–43 (In Russ., English abstract).

11. Agnello F., Ronot M., Valla D. C., Sinkus R., Van Beers B. E., Vilgrain V. High b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology. 2012; 262(2): 511–519. DOI: 10.1148/radiol.11110922

12. Grazioli L., Federle M. P., Brancatelli G., Ichikawa T., Olivetti L., Blachar A. Hepatic Adenomas: Imaging and Pathologic Findings. RadioGraphics. 2001; 21(4): 877–892. DOI: 10.1148/radiographics.21.4.g01jl04877

13. Giannitrapani L., Soresi M., La Spada E., Cervello M., D’Alessandro N., Montalto G. Sex hormones and risk of liver tumor. J. Ann. NY Acad. Sci. 2006; 1089(1): 228–236. DOI: 10.1196/annals.1386.044

14. Ribeiro Junior M. A., Chaib E., Saad W. A., D’Albuquerque L. A., Cecconello I. Surgical management of spontaneous ruptured hepatocellular adenoma. Clinics. 2009; 64(8): 775–779. DOI: 10.1590/s1807-59322009000800011

15. Bieze M., Phoa S. S., Verheij J., van Lienden K. P., van Gulik T. M. Risk factors for bleeding in hepatocellular adenoma. Br. J. Surg. 2014; 101(7): 847–855. DOI: 10.1002/bjs.9493

16. Reeves H., Manas D. M., Lochaan R. Liver tumors — epidemiology, diagnosis, prevention and treatent. InTech, Chapters published April 10, 2013 under CC BY 3.0. 184 p. DOI: 10.5772/56514

17. Farges O., Ferreira N., Dokmak S., Belghiti J., Bedossa P., Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. J. Gut. 2011; 60(1): 85–89. DOI: 10.1136/gut.2010.222109

18. Foster J. H., Berman M. M. The malignant transformation of liver cell adenomas. J. Arch. Surg. 1994; 129(7): 712–717. DOI: 10.1001/archsurg.1994.01420310044007

19. Trufanov G. E., Bagnenko S. S., Rud’ S. D. Luchevaya diagnostika zabolevanii pecheni. Saint-Peterburg: ELBI-SPb.; 2011. 415 р. (In Russ.). 20. Colombo M. EASL Clinical Practice Guidelines on the management of benign liver tumours. J. Hepatol. 2016; 65(2): 386–398. DOI: 10.1016/j.jhep.2016.04.001

20. Westwood M., Joore M., Grutters J., Redekop K., Armstrong N., Lee K., Gloy V., Raatz H., Misso K., Severens J., Kleijnen J. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafl uoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. J. Health Tech. Ass. 2013; 17(16): 1–243. DOI: 10.3310/hta17160

21. Sonov’yu. Nauchnaya monografi ya. Dinamicheskoe kontrastnoe usilenie v rezhime real’nogo vremeni. Moscow: Bracco; 2014. 45 р. (In Russ.). 23. Weskott H.-P. Сontrast sonography. Bremen: UNI–MED; 2014. 284 р. (In Russ.).

22. Katabathina V. S., Menias C. O., Shanbhogue A. K., Jagirdar J., Paspulati R. M., Prasad S. R. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011; 31(6): 1529–1543. DOI: 10.1148/rg.316115527

23. Nault J. C., Bioulac-Sage P., Zucman-Rossi J. Hepatocellular benign tumors-from molecular classifi cation to personalized clinical care. Gastroenterology. 2013; 144(5): 888–902. DOI: 10.1053/j.gastro.2013.02.032

24. Pilati C., Letouze E., Nault J. C., Imbeaud S., Boulai A., Calderaro J., Poussin K., Franconi A., Couchy G., Morcrette G., Mallet M., Taouji S., Balabaud C., Terris B., Canal F., Paradis V., Scoazec J. Y., de Muret A., Guettier C., Bioulac-Sage P., Chevet E., Calvo F., Zucman-Rossi J. Genomic profi ling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. J. Cancer Cell. 2014; 25(4): 428–441. DOI: 10.1016/j.ccr.2014.03.005

25. Zucman-Rossi J., Jeannot E., Nhieu J. T., Scoazec J. Y., Guettier C., Rebouissou S., Bacq Y., Leteurtre E., Paradis V., Michalak S., Wendum D., Chiche L., Fabre M., Mellottee L., Laurent C., Partensky C., Castaing D., Zafrani E. S., Laurent-Puig P., Balabaud C., Bioulac-Sage P. Genotype-phenotype correlation in hepatocellular adenoma: new classifi cation and relationship with HCC. Hepatology. 2006; 43(3): 515–524. DOI: 10.1002/hep.21068

26. Yen Y. H., Wang J. H., Lu S. N., Chen T. Y., Changchien C. S., Chen C. H., Hung C. H., Lee C. M. Contrast-enhanced ultra-sonographic spoke-wheel sign in hepatic focal nodular hyperplasia. Eur. J. Radiol. 2006; 60(3): 439–444. DOI: 10.1016/j.ejrad.2006.06.007

27. Hussain S. M., van den Bos I. C., Dwarkasing R. S., Kuiper J. W., Hollander J. Hepatocellular adenoma: Findings at state-of-the-Art MR Imaging, US, CT, and Pathologic Analysis. J. Eur. Radiol. 2006; 16(9): 1873–1886. DOI: 10.1007/s00330-006-0292-4

28. Dietrich C. F., Schuessler G., Trojan J., Fellbaum C., Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br. J. Radiol. 2005; 78(932): 704–707. DOI: 10.1259/bjr/88181612


Review

For citations:


Katrich A.N., Ryabinin N.S., Polshikov S.V., Katrich N.A. CONTRAST-ENCHANCED ULTRASOUND IN THE DIFFERENTIAL DIAGNOSIS OF FOCAL NODULAR HYPERPLASIA AND HEPATIC ADENOMA. Kuban Scientific Medical Bulletin. 2019;26(2):50-63. (In Russ.) https://doi.org/10.25207/1608-6228-2019-26-2-50-63

Views: 864


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1608-6228 (Print)
ISSN 2541-9544 (Online)